Free Trial

Short Interest in Oscar Health, Inc. (NYSE:OSCR) Rises By 118.5%

Oscar Health logo with Finance background

Key Points

  • Oscar Health, Inc. saw a 118.5% increase in short interest during July, with a total of 62,480,000 shares short sold as of July 15th.
  • The company reported a net margin of 1.22% and a year-over-year revenue increase of 42.2%, achieving $3 billion during its last quarterly earnings.
  • Several brokerages revised their ratings and price targets for Oscar Health, with Barclays and UBS setting an "underweight" rating and a target of $11.00 per share.
  • Want stock alerts on Oscar Health? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totaling 62,480,000 shares, agrowthof118.5% from the June 30th total of 28,590,000 shares. Based on an average trading volume of 21,750,000 shares, the short-interest ratio is currently 2.9 days. Currently,34.7% of the shares of the stock are short sold. Currently,34.7% of the shares of the stock are short sold. Based on an average trading volume of 21,750,000 shares, the short-interest ratio is currently 2.9 days.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on OSCR. Piper Sandler lowered Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price target on the stock. in a report on Monday, July 14th. UBS Group reissued a "sell" rating and issued a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Baird R W cut shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. Wall Street Zen lowered shares of Oscar Health from a "buy" rating to a "hold" rating in a research report on Sunday, June 8th. Finally, Robert W. Baird restated a "neutral" rating and set a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Five research analysts have rated the stock with a sell rating and five have given a hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $12.21.

Get Our Latest Stock Report on Oscar Health

Insider Activity at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the sale, the director owned 64,512 shares in the company, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 24.39% of the stock is owned by insiders.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OSCR. LRI Investments LLC raised its position in Oscar Health by 377.9% during the second quarter. LRI Investments LLC now owns 1,233 shares of the company's stock worth $26,000 after acquiring an additional 975 shares during the period. Jones Financial Companies Lllp lifted its position in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock valued at $30,000 after acquiring an additional 2,242 shares in the last quarter. Strs Ohio purchased a new stake in shares of Oscar Health during the first quarter worth approximately $30,000. Larson Financial Group LLC lifted its holdings in Oscar Health by 83,733.3% in the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock valued at $33,000 after purchasing an additional 2,512 shares in the last quarter. Finally, Atlantic Union Bankshares Corp acquired a new stake in Oscar Health during the 2nd quarter worth $33,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Trading Up 3.9%

OSCR opened at $14.36 on Thursday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.22. The stock's fifty day moving average is $15.84 and its two-hundred day moving average is $14.87. The company has a market capitalization of $3.66 billion, a P/E ratio of 51.29 and a beta of 1.86. Oscar Health has a 52 week low of $11.20 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, missing analysts' consensus estimates of $0.34 by ($1.23). Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The firm's revenue was up 29.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.20 earnings per share. Analysts forecast that Oscar Health will post 0.69 earnings per share for the current year.

About Oscar Health

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Read More

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines